# A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy

> **NCT00209586** · PHASE3 · TERMINATED · sponsor: **Eisai Inc.** · enrollment: 55 (actual)

## Conditions studied

- Flexible Bronchoscopy

## Interventions

- **DRUG:** fospropofol disodium

## Key facts

- **NCT ID:** NCT00209586
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Patient enrollment was stopped prior to completion of the study in order to re-evaluate the dosing regimen.
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209586, "A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00209586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*